Max Planck supports open access to research

The Max Planck Society has become a BioMed Central Institutional Member. This move, by one of the world's premier scientific research organisations, follows a recent call by some German politicians for government and state funded research to be published online and freely available.

The German taxpayer provides 95% of the Max Planck Society's funding, yet the findings of research are rarely freely accessible to the public. Talking particularly about university researchers, German politician Gtz von Stumpfeldt for instance said:

"Most professors at German universities are state funded, but their findings are only published in expensive trade journals. These magazines then have to be bought by libraries, again using taxpayers money."

It is now hoped that other German universities will follow Max Planck's lead in making their institution's research freely available to the worldwide scientific community, and to the taxpayers that fund it. The Universitt Gttingen, itself a prestigious research university, was the first BioMed Central member in Germany.

By signing up for BioMed Central membership Max Planck has ensured that article-processing charges are waived - for any of the more than 3000 researchers it employs - for publication in any of BioMed Central's 90 peer-reviewed journals in which all the research content is free. BioMed Central is the largest open access publisher of biology and medicine journals, with a business model based on charging for research articles to be published and then making the content free to readers. Upon acceptance, the article becomes immediately freely available through the Internet to readers worldwide.

A number of Max Planck researchers have already published in BioMed Central's journals. With over 100 articles already published by German authors, BioMed Central reports that Germany is in the top five countries worldwide in terms of both the

Contact: Grace Baynes
BioMed Central

Page: 1 2 3

Related biology news :

1. 2004 Max Planck Research Prize for Martin Vingron and Eugene W. Myers
2. Max Planck Research awards 2003 presented
3. Two Max Planck researchers recieve the Louis-Jeantet Prize for Medicine 2003
4. Max-Planck doctoral student discovers living fossils
5. One Way Traffic: Max Planck Scientists Idendified Genes Involved In Transporting An Important Plant Growth Factor
6. Team Of Max Planck Scientists Elucidates Structure Of A Protein Segment Involved In Von Recklinghausen Neurofibromatosis
7. Max Planck Scientists Report Molecular Details On The Interaction Of The Stress Hormone Corticotropin-Releasing Factor (CRF) And Its Receptor
8. Towards A Local Stimulation Of Natural Bypass Growth - Max Planck Scientists Developed New Treatment For Ischemic Heart Disease
9. Max-Planck Researchers Unravel The Structure Of The Methane Forming Enzyme
10. Potential for enhanced sequestration of carbon in soils supports evaluations
11. Reading hexametric rhyme supports cardiac synchronization, especially after a heart attack

Post Your Comments:

(Date:6/28/2020)... ... June 25, 2020 , ... ... biopharmaceutical R&D, today announced that it has entered into a multi-year contract ... (Multiclonics®), to support their translational and clinical research strategy to discover and ...
(Date:6/25/2020)... ... June 24, 2020 , ... eClinical ... clinical data services that accelerate drug development, is collaborating with Karyopharm Therapeutics (Nasdaq: ... in hospitalized patients with severe COVID-19. This is the first study of an ...
(Date:6/23/2020)... ... June 23, 2020 , ... First Aid Africa, a ... UK supplier and manufacturer of innovative portable renewable energy equipment, have announced the ... against the COVID-19 pandemic in Zambia. , One of Renovagen’s FAST FOLD portable ...
Breaking Biology News(10 mins):
(Date:9/1/2020)... ... September 01, 2020 , ... Slone Partners , ... announced the placement of Julianne Averill , CPA, as Chief Financial Officer ... operations and implementing key business strategies to accelerate Alveo’s growth as the company ...
(Date:8/12/2020)... ... August 11, 2020 , ... ... available for free its new white paper – Simulated Transport Methodologies. Regulatory ... today’s biologics licensing application (BLA). In response, Modality Solutions shares an explanation ...
(Date:7/31/2020)... ... 2020 , ... R3 Stem Cell International is now offering patients the opportunity ... cells total, patients may choose which extremities they would like treated. , Several studies ... Disord. 2016). At R3 International, umbilical cord tissue is obtained from a lab with ...
(Date:7/31/2020)... ... 29, 2020 , ... eSource has long been touted as the solution to ... of eSource, the reasons it did not take off as quickly as people initially ... industry is moving towards capturing data electronically for clinical trials and then repurposing it ...
Breaking Biology Technology:
Cached News: